7th Jan 2008 12:06
Verona Pharma plc (the "Company") Result of General Meeting and Directors' Shareholdings
The Company can confirm that all resolutions put to shareholders at today's general meeting of the Company have been duly approved, including the special resolution to authorise the directors to allot 57,983,325 new ordinary shares of 0.1p each in the Company ("New Ordinary Shares") at 4p per share (the "Placing").
Application has been made for the New Ordinary Shares to be admitted to trading on AIM and admission is expected to occur on 8 January 2008 ("Admission"). On Admission, the Company will have a total of 204,758,325 shares in issue.
The following directors participated in the Placing:
Director Shares New Shareholding Percentage Holding Stuart Bottomley 1,000,000 9,450,000 4.62% Claire Poll 500,000 3,500,000 1.71%
For further information please contact:
Professor Clive Page, Chairman, Verona Pharma plc: 07971 504 931
David Youngman, WH Ireland Ltd: 0161 832 2174
Allan Piper, First City Financial Public Relations: 020 7242 2666
VERONA PHARMA PLCRelated Shares:
VRP.L